Skip to main content
UniHealth

Doctor search

Sean Austin Mcghee, MD

Allergy/Immunology · Palo Alto

NPI 1083721351

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
1 carrier
Offices
2

Offices

2 locations · Lpch Medical Group Div of Lucile · Stanford Health Care

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

12 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mcghee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A70048 · Current

Licensed to practise in California · since 1999 · expires 2027-07-31 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$2,156

Medicare paid this office $2,156 for 15 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Who their Medicare patients are

15 Original Medicare patients in 2024. Average age 63 · Health risk score 2.22. Sicker patients than 9 in 10 peers; the typical allergy/ immunology clinician is at 1.

The office billed $10,517, Medicare allowed $2,705 and paid $2,156; for 22 services of 7 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20241522632.22$10,517$2,156
202115226671.70$30,440$6,513
20191827662.96$9,801$2,640
20182540641.60$7,552$2,572
20173451633.26$11,654$3,699
20161217631.28$3,713$1,188
20151323712.60$7,905$2,265
20141425661.98$6,385$1,826
20132134701.54$9,380$2,114

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2018: 1 service

Original Medicare services billed in 2018
Short return visit (20+ min)11$447$37

Medicaid work

$1,796 in 2024

Medicaid paid $1,796 for 17 billed services this clinician did in 2024, up to 16 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)17$1,796
Medicaid work by year
202417116$1,796
2023136221$8,150
202238213$2,429
2021194319$4,205
2020247217$5,380
201975122$4,205
201854216$2,582
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Return visit (30+ min)94$7,715
ANTIGEN THERAPY SERVICES42$436

2022

Largest Medicaid services in 2022
Return visit (30+ min)25$1,860
Short return visit (20+ min)13$569

2021

Largest Medicaid services in 2021
ANTIGEN THERAPY SERVICES155$1,805
Return visit (30+ min)27$1,749
Short return visit (20+ min)12$650

2020

Largest Medicaid services in 2020
Return visit (30+ min)46$3,035
ANTIGEN THERAPY SERVICES201$2,345

2019

Largest Medicaid services in 2019
Return visit (30+ min)75$4,205

2018

Largest Medicaid services in 2018
Return visit (30+ min)41$2,207
Short return visit (20+ min)13$376

Drugs they prescribed that Part D paid

$164,447

Pharmacies billed $164,447 in 2024. Most of that is one immune-globulin drugs at about $10,000 a fill for a small number of people.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 27) in 2024. Too few prescriptions to compare fairly with other clinicians.

0 generic and 21 brand-name prescriptions · $164,447 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
HizentraImmune globulin12$125,224$10,435

Year by year

Part D prescribing by year
202427None0% (0)78%$164,447
202317None0% (0)88%$152,785
202218None0% (0)83%$136,004
202134None0% (0)68%$155,869
202015None0% (0)None$50,381
201919None0% (0)None$3,802
201829None0% (0)None$3,187
201743110% (0)35%$264,923
201424None0% (0)None$7,353
201343110% (0)42%$15,676

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 1 drug

Part D drugs prescribed in 2023
HizentraImmune globulin14$152,485$10,892

2022: 1 drug

Part D drugs prescribed in 2022
HizentraImmune globulin13$135,589$10,430

2021: 1 drug

Part D drugs prescribed in 2021
HizentraImmune globulin12$116,171$9,681

2014: 1 drug

Part D drugs prescribed in 2014
Danazol13$5,272$406

2013: 1 drug

Part D drugs prescribed in 2013
Danazol11$4,800$436

Money from drug and device companies

$151 in 2025

Industry payments by year
202522None$151
202312None$143
202222None$238
202111None$92
201911None$106

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Ionis PharmaceuticalsDawnzera$124
1 payment
  • Meals for Dawnzera · 2025-11-11 · $124
Regeneron Healthcare SolutionsDupixent$27
1 payment
  • Meals for Dupixent · 2025-05-05 · $27
See all 2 published payments
Every published payment
Ionis PharmaceuticalsMeals · 2025-11-11Dawnzera$124
Regeneron Healthcare SolutionsMeals · 2025-05-05Dupixent$27
See earlier years (2023, 2022, 2021, 2019)

2023: $143

Payments by company in 2023
BioCryst US Sales Co.Orladeyo$143
2 payments
  • Meals for Orladeyo · 2023-04-29 · $137
  • Education · 2023-02-01 · $6

2022: $238

Payments by company in 2022
BioCryst US Sales Co.Orladeyo$140
1 payment
  • Meals for Orladeyo · 2022-05-21 · $140
Regeneron Healthcare SolutionsDupixent$98
1 payment
  • Meals for Dupixent · 2022-11-08 · $98

2021: $92

Payments by company in 2021
kaleoAuvi-Q$92
1 payment
  • Meals for Auvi-Q · 2021-09-11 · $92

2019: $106

Payments by company in 2019
Teva Pharmaceuticals USACinqair$106
1 payment
  • Meals for Cinqair · 2019-04-20 · $106

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1083721351
Licence
CA A70048California A70048: Current · expires 2027-07-31
Trained
Stanford University School of Medicine, 1998
Group
Lpch Medical Group Div of Lucile · Stanford Health Care
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A700480, CA GR0053510
Taxonomy
Federal specialty code 2080P0201X (2080P0201X); Federal specialty code 207K00000X (207K00000X)
Mailing address
725 Welch Rd, Palo Alto, CA, 94304
NPI first listed
2006-08-24
NPI last updated
2024-04-09
NPI record certified
2024-04-09

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 269 Campus Dr Rm 2115, Stanford, CA, 94305